• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    Chinese Journal of Cancer Prevention and Treatment

    Chinese Journal of Cancer Prevention and Treatment

    JournalISSN 1673-5269

    年发文量

    研究主题

    论文(11075)

    排序
    1Consensus on the Diagnosis and Treatment of Unresectable Stage III Driver Gene-Positive Non-Small Cell Lung Cancer.
    Xiangjiao Meng,Nan Bi,Jun Wang,Xue Meng,Jianbo Wang,Ligang Xing,Yufeng Cheng,Shun Lu,Ming Chen,Jinming Yu

    Unresectable stage III non-small cell lung cancer (NSCLC) exhibits substantial heterogeneity and complexity. The landmark LAURA and POLESTAR studies have established a standard therapeutic model involving targeted consolidation therapy with osimertinib or aumolertinib after definitive chemoradiotherapy for NSCLC patients harboring EGFR-sensitive mutations. However, treatment strategies for patients with other driver gene mutations (e.g., ALK fusions, ROS1 rearrangement) still lack robust support from high-level evidence-based medical study. To enhance the standardization of diagnosis and treatment for unresectable stage III driver-positive NSCLC patients, the Radiotherapy Committee of the Chinese Society of Clinical Oncology convened an expert working group. This group identified common clinical practice issues and conducted an in-depth, problem-oriented analysis of domestic and international guidelines alongside evidence-based medical data. Through multiple rounds of comprehensive discussion and expert voting, this consensus was jointly developed. It provides evidence-based recommendations addressing frequently encountered clinical questions regarding unresectable stage III driver-positive NSCLC, aiming to serve as a key reference for clinical practice.

    2026引用:1
    引用
    AI阅读
    加入学术空间
    2[Analysis of the Incidence and Mortality of Thyroid Cancer in Shandong Province from 2012 to 2022 Based on the Age-Period-cohort Model].
    F Jiang,Z T Fu,Z L Lu,J Chu,X L Guo,A Q Xu,J X Ma

    Objective: To analyze the trend of incidence and mortality of thyroid cancer and estimate its age-period-cohort effect in Shandong Province from 2012 to 2022. Methods: The Joinpoint regression was used to analyze the trend of incidence and mortality of thyroid cancer and calculate the average annual percentage change (AAPC) based on the data on thyroid cancer from 2012 to 2022. The age-period-cohort model was used to analyze the age-effect, time-effect and cohort-effect of thyroid cancer risk in the population aged over 20 years. Results: From 2012 to 2022, the incidence of thyroid cancer in Shandong province showed a significant upward trend, with an AAPC of 21.68% (95%CI: 19.14%-24.27%, P<0.001). The incidence of females was higher than that of males, and the incidence of urban areas was higher than that of rural areas. The trend of thyroid cancer mortality was relatively stable with an AAPC of -3.04% (95%CI:-8.81%-3.09%, P=0.323). The age effect of incidence increased with age before 60 years old and decreased with age after 60 years old. The incidence peaked in the age group of 55-59. The period effect increased with time. The cohort effect showed that the cohort born before 1957 had a downward trend over time, while the cohort born after 1957 had an upward trend. Conclusion: The incidence of thyroid cancer in Shandong shows a rising trend from 2012 to 2022. Age is an important factor affecting the risk of thyroid cancer. The mortality of thyroid cancer remains stable.

    2024
    引用
    AI阅读
    加入学术空间
    3Perturbation of Gut Microbiota Modulated the Abscopal Effects of Immunoradiotherapy in Rectal Cancer.
    Z. Xue,X. Zhang,J. Yue

    Purpose/Objective(s) The abscopal effect—the regression of malignancies outside the irradiation zone—can be increased by combining radiotherapy (RT) with immunotherapy. In this study, we aimed to investigate whether the gut microbiota affected the abscopal effect following immunoradiotherapy (iRT) in rectal cancer. Materials/Methods Bilateral MC38 subcutaneous tumors (primary and abscopal tumor) were established in C57/B6 mice with or without oral antibiotic treatment (preadministration of vancomycin, streptomycin, and ampicillin 14 days before therapy). Mice with or without antibiotic therapy were then randomized into eight groups to receive one of four treatments: (1) RT to the primary tumor + anti-PD-1 therapy (iRT), (2) RT to the primary tumor (RT), (3) anti-PD-1 therapy (anti-PD-1), and (4) no treatment. Flow cytometry was used to determine the composition and function of immune cells in the primary and abscopal tumors as well as in the spleen. 16S rRNA sequencing was used to assess the gut microbiome alteration following antibiotic intervention. Multiple bioinformatics were then explored to investigate the impact of specific flora that related to abscopal antitumor effect. Results We found that radiation on primary tumors exhibited cytotoxic effect in nonirradiated (abscopal) tumors (p=0.0057, RT vs. untreated group; p=0.0037, iRT vs. anti-PD-1 group). In contrast, abscopal tumors were resistant to the anticancer effects of RT when antibiotics were given (p=0.5374, RT + antibiotics vs. untreated group + antibiotics; p=0.42, iRT + antibiotics vs. anti-PD-1 + antibiotics group). Comparing the RT+antibiotics group to the RT group, we discovered that the number of CD8+CD44+ T cells decreased significantly in both abscopal tumors (p<0.001) and spleens (p=0.0061). In anti-PD-1-treated groups, antibiotics significantly reduced the number of CD8+GranzymeB+ T cells in primary tumors (p=0.0061) and CD4+CD25+ T cells in spleens (p<0.001). In iRT-treated groups, the antibiotic reduced the fraction of CD4+INF-γ+ cells in abscopal tumors (p=0.0134), and increased the number of CD4+PD-1+ T cells in spleens (p<0.001). Moreover, we found that both α- and β-diversity decreased significantly in the gut microbiota after antibiotic treatment (p=0.0079 and p<0.001, respectively). The abundance of g_Alistipes, g_Lactobacillus, g_Lachnospiraceae and g__Lactobacillus fell dramatically in the presence of antibiotics. In addition, functional analyses of Picrust2 and KEGG revealed that antibiotic therapy had the most profound impact on the D-Alanine metabolism pathway (p<0.001). Conclusion We found that the alteration of the gut microbiome by antibiotics significantly affects the local and systemic antitumoral effect of iRT, our results may provide new insight on how gut modification converts the local anticancer effects of RT into a systemic response that targets metastatic tumors.

    2024
    引用
    AI阅读
    加入学术空间
    4An Ultrasound-Based Nomogram Model in the Assessment of Pathological Complete Response of Neoadjuvant Chemotherapy in Breast Cancer
    Jinhui Liu,Xiaoling Leng, Wen Liu, Yuexin Ma, Lin Qiu, Tuerhong Zumureti,Haijian Zhang, Yeerlan Mila

    IntroductionWe aim to predict the pathological complete response (pCR) of neoadjuvant chemotherapy (NAC) in breast cancer patients by constructing a Nomogram based on radiomics models, clinicopathological features, and ultrasound features.MethodsUltrasound images of 464 breast cancer patients undergoing NAC were retrospectively analyzed. The patients were further divided into the training cohort and the validation cohort. The radiomics signatures (RS) before NAC treatment (RS1), after 2 cycles of NAC (RS2), and the different signatures between RS2 and RS1 (Delta-RS/RS1) were obtained. LASSO regression and random forest analysis were used for feature screening and model development, respectively. The independent predictors of pCR were screened from clinicopathological features, ultrasound features, and radiomics models by using univariate and multivariate analysis. The Nomogram model was constructed based on the optimal radiomics model and clinicopathological and ultrasound features. The predictive performance was evaluated with the receiver operating characteristic (ROC) curve.ResultsWe found that RS2 had better predictive performance for pCR. In the validation cohort, the area under the ROC curve was 0.817 (95%CI: 0.734-0.900), which was higher than RS1 and Delta-RS/RS1. The Nomogram based on clinicopathological features, ultrasound features, and RS2 could accurately predict the pCR value, and had the area under the ROC curve of 0.897 (95%CI: 0.866-0.929) in the validation cohort. The decision curve analysis showed that the Nomogram model had certain clinical practical value.DiscussionThe Nomogram based on radiomics signatures after two cycles of NAC, and clinicopathological and ultrasound features have good performance in predicting the NAC efficacy of breast cancer.

    2023引用:2
    引用
    AI阅读
    加入学术空间
    5Progress in photodynamic immunotherapy of cancers
    ZHONG Liqing,LIU Qin,LIU Baorui

    光动力治疗具有毒副作用小、适用瘤种广和可反复治疗等优势,在临床上已用于食管癌、中央型肺癌、脑胶质瘤等的根治、辅助或姑息治疗.光动力治疗除了通过产生活性氧,直接杀伤肿瘤细胞外,还可产生肿瘤原位疫苗,引起肿瘤的免疫原性细胞死亡,促进树突状细胞的成熟和细胞毒性T细胞的浸润,具有一定免疫治疗的属性.但光动力治疗存在氧气依赖和光敏剂的肿瘤选择性不足等缺陷,且单独光动力治疗诱导的弱免疫不足以触发全身抗肿瘤免疫反应.本文重点介绍光动力免疫治疗的机制,并针对上述不足阐述提高光动力免疫治疗疗效的策略.

    2023
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 11075 篇论文

    高被引作者

    作者引用发文
    YuMing Ji19284
    GuoKuan Yang19012
    Xiaonong Zou8085
    Jinming Yu75489
    Jingxuan Wang7462
    Qingyuan Zhang7462
    WenShu Zuo73770
    Dawei Chen4832
    Idris Bahce4811
    Verma Vivek4811

    高产作者

    作者引用发文
    Jinming Yu75489
    WenShu Zuo73770
    Xiugui Sheng30556
    Jialin Wang30243
    Yong Yin9341
    Jianbin Li16533
    Qi Wang24931
    Shulan Zhang22231
    BaiJiang Zhang19431
    Baosheng Li17028

    相关期刊

    Zhongguo fei ai za zhi = Chinese journal of lung cancer
    Chinese Journal of Oncology
    Chinese Journal of Clinical Oncology
    Journal of Modern Oncology
    China Oncology
    Cancer Research on Prevention and Treatment
    China Cancer
    Journal of Cancer Control and Treatment
    Oncology Progress
    Practical Oncology Journal